Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

May 16, 2022

BUY
$3.78 - $4.66 $228,312 - $281,464
60,400 Added 188.16%
92,500 $404,000
Q4 2021

Feb 14, 2022

BUY
$4.12 - $6.35 $15,244 - $23,495
3,700 Added 13.03%
32,100 $146,000
Q3 2021

Nov 15, 2021

SELL
$5.76 - $9.95 $176,832 - $305,465
-30,700 Reduced 51.95%
28,400 $171,000
Q2 2021

Aug 11, 2021

BUY
$4.7 - $16.7 $109,510 - $389,110
23,300 Added 65.08%
59,100 $612,000
Q1 2021

May 17, 2021

BUY
$3.79 - $9.78 $135,682 - $350,124
35,800 New
35,800 $274,000

About Nemaura Medical Inc.


  • Ticker NMRD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,102,900
  • Description
  • Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes...
More about NMRD
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.